Recent Posts
- Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024
- Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30
- Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
- Elutia Celebrates First Year; Company Thanks Stakeholders and Employees for a Year of Remarkable Growth and Accomplishment
- Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators